Isolating Exosomes for Cancer Diagnostics

Article   Nov 08, 2017 | By Anna MacDonald, Editor for Technology Networks

 
Isolating Exosomes for Cancer Diagnostics

Anna Macdonald

Science Writer

 
 
 

RELATED ARTICLES

Microfluidic Method Identifies Rare Antibodies with Therapeutic Potential

Article

A novel microfluidic platform, able to rapidly isolate and identify rare antibodies from a vast repertoire of human B cells, has been developed by scientists. This technology could possess the ability to support and enhance the development of novel vaccines and biopharmaceuticals in the future.

READ MORE

The Cancer Moonshot 2020: Then, Now & the Future

Article

Since the launch of the project, patients, caregivers, doctors, cancer centers, regulators and others have been hard at work to drive cancer research and treatment forward in a race to beat the disease.

READ MORE

Liquid Biopsies Coming of Age

Article

Based on the analysis of cells, genes, and chemical signals in body fluids, liquid biopsies provide timely, actionable information on disease states while eliminating the high cost and risks of tissue biopsies. Gene amplification through polymerase chain reaction and related techniques offer these benefits with the added advantage of amplifying low-abundance species. This article looks at the state of the art in PCR-based liquid biopsies, including a discussion of the technique's limitations.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE